Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China

NCT00408993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: Duloxetine Hydrochloride
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]